Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Efthimia N Melissari"'
Autor:
Maria Theodorou, Mary Mavri-Vavayanni, Eugenia Iliopoulou, Dimitrios Degiannis, Christos Kroupis, Maria Kounavi, Efthimia N Melissari, Samantha C. Oliveira
Publikováno v:
Clinical Biochemistry. 42:1685-1693
Objective The FcγRIIa receptor is responsible for the activation of platelets by antibodies in heparin-induced thrombocytopenia (HIT). The c.497G > A polymorphism in the corresponding FCG2RA gene (H131R) has been implicated in the HIT syndrome and w
Autor:
Sotirios Prapas, Sophia Mardaki, George M. Palatianos, Efthimia N Melissari, Eugenia Iliopoulou, I Loukas Kaklamanis, Mary I. Vassili, Poli Stratigi, Konstantinos E. Paziouros, Matthew Panagiotou
Publikováno v:
ASAIO Journal. 51:398-403
We tested the hypothesis that nitric oxide (NO) administered during cardiopulmonary bypass (CPB) would preserve platelets and prevent postperfusion lung changes. Ten anesthetized Yorkshire pigs were put on normothermic CPB (right atrium to aorta) wit
Autor:
Christophoros N. Foroulis, Eugenia Iliopoulou, Maria I Vassili, George M Astras, Efthimia N Melissari, Angela A Lidoriki, Emmanuel G. Papadakis, George M. Palatianos, Konstantinos Triantafillou
Publikováno v:
The Annals of Thoracic Surgery. 76:129-135
Background We evaluated the newly introduced Bioline heparin coating and tested the hypothesis that surface heparinization limited to the oxygenator and the arterial filter will ameliorate systemic inflammation and preserve platelets during cardiopul
Autor:
Efthimia N Melissari, Konstantinos E. Paziouros, Eugenia Iliopoulou, Sotirios Prapas, S Mardaki, Matthew Panagiotou, L Kaklamanis, Mary I. Vassili, George M. Palatianos, P Stratigi
Publikováno v:
ASAIO Journal. 49:152
Autor:
George H Kantidakis, Eugenia Iliopoulou, Efthimia N Melissari, Christophoros N. Foroulis, Maria I Vassili, George M. Palatianos, George M Astras, Phaedra Matsouka
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. (2):548-554
ObjectiveThe objective of this study was to evaluate our protocol for the identification and management of patients with immune heparin-induced thrombocytopenia undergoing cardiac surgery.MethodsAmong 1518 patients who underwent cardiac surgery betwe